Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds-Reference-Cited by-同舟云学术

Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds

Published:2018-01 Issue:1 Volume:26 Page:56-69
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Selman Mohammed,Rousso Christopher,Bergeron Anabel,Son Hwan Hee,Krishnan Ramya,El-Sayes Nader A.,Varette Oliver,Chen Andrew,Le Boeuf Fabrice,Tzelepis Fanny,Bell John C.,Crans Debbie C.,Diallo Jean-Simon

Funder

Canadian Institute for Health Research

CIHR

Terry Fox Research Institute

Canadian Cancer Society

Lotte & John Hecht Memorial Foundation

Queen Elizabeth II Graduate Scholarship in Science & Technology

BioCanRx

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference69 articles.

1. From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancer;Ilkow;PLoS Pathog.,2014

2. Oncolytic virotherapy;Russell;Nat. Biotechnol.,2012

3. Oncolytic virus-mediated immunotherapy: a combinatorial approach for cancer treatment;Lawler;J. Clin. Oncol.,2015

4. Talimogene laherparepvec improves durable response rate in patients with advanced melanoma;Andtbacka;J. Clin. Oncol.,2015

5. Oncolytic maraba virus MG1 as a treatment for sarcoma;Le Boeuf;Int. J. Cancer,2017

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Solution chemistry and anti-proliferative activity against glioblastoma cells of a vanadium(V) complex with two bioactive ligands;Frontiers in Chemical Biology;2024-07-05

2. Tepilamide Fumarate as a Novel Potentiator of Virus-Based Therapy;Viruses;2024-06-05

3. Exploiting bacterial effector proteins to uncover evolutionarily conserved antiviral host machinery;PLOS Pathogens;2024-05-16

4. Exploiting Bacterial Effector Proteins to Uncover Evolutionarily Conserved Antiviral Host Machinery;2024-01-30

5. Unlocking the potential of dimethyl fumarate: enhancing oncolytic HSV-1 efficacy for wider cancer applications;Frontiers in Immunology;2023-12-19